Putting eye drops in your nose delivers medication to a mucous membrane that absorbs drugs into the bloodstream much more efficiently than the eye does. In most cases, a drop or two won’t cause serious harm, but it can produce unexpected side effects, and some eye drop formulations are genuinely dangerous when absorbed through nasal tissue, especially for children.
Your Eyes Already Drain Into Your Nose
This might be the most surprising part: every time you use eye drops normally, some of the liquid ends up in your nose anyway. A drainage system called the nasolacrimal duct connects your eyes to your nasal cavity. Small openings on the inner edge of each eyelid (upper and lower) lead into tiny canals that flow into a tear-collecting sac, which then empties through a duct that opens underneath a structure inside your nose called the inferior turbinate. That’s why you sometimes taste eye drops in the back of your throat after using them.
So the question isn’t really whether eye drops reach your nose. It’s what happens when you bypass the eye entirely and put them directly on nasal tissue, where absorption is faster and more complete.
Nasal Tissue Absorbs Drugs Much Faster
The lining inside your nose is highly vascularized, meaning it’s packed with blood vessels sitting just beneath the surface. When a drug lands on nasal mucosa, it enters the bloodstream rapidly, sometimes within minutes. The eye’s surface absorbs medication too, but far less efficiently because tears dilute the drug, blinking washes it away, and most of the dose drains out before it can be absorbed.
Dropping eye drops directly into the nose skips all of those natural barriers. You get a larger dose absorbed more quickly, which increases the risk of systemic side effects: effects that show up not just locally but throughout the body.
Eye Drops and Nasal Sprays Often Share the Same Ingredients
Several of the active ingredients in redness-relieving eye drops are the same compounds found in nasal decongestant sprays. Tetrahydrozoline (the active ingredient in Visine), naphazoline, and oxymetazoline all belong to a class of drugs called imidazolines. They work by constricting blood vessels, which is why they reduce redness in the eye and shrink swollen tissue in the nose.
The key difference is concentration. Eye drops typically contain tetrahydrozoline at 0.05%, while nasal sprays may use higher concentrations of the same or related compounds formulated specifically for nasal tissue. Putting eye drops in your nose delivers a vasoconstrictor to tissue that will absorb it efficiently, but at a concentration and volume that wasn’t designed for that route. This can still produce a temporary decongestant effect, which is likely why some people try it, but the risks outweigh any improvised benefit.
Side Effects in Adults
For a healthy adult, a drop or two of a standard redness-relief eye drop in the nose is unlikely to cause a medical emergency, but it can produce noticeable effects. Imidazoline compounds absorbed through nasal tissue can cause a drop in heart rate, lowered blood pressure, and drowsiness. These effects are usually mild at small doses but become more pronounced with repeated use or larger amounts.
There’s also the issue of rebound congestion. Nasal decongestant sprays are notorious for causing worsening stuffiness when used for more than a few days in a row. The same vasoconstricting ingredients in eye drops can trigger the same cycle if applied to nasal tissue regularly. Your nasal blood vessels compensate for the repeated constriction by dilating even more when the drug wears off, leaving you more congested than when you started.
Preservatives Can Damage Nasal Tissue
Most multi-use eye drop bottles contain a preservative called benzalkonium chloride to prevent bacterial contamination. This chemical has a well-documented effect on the tiny hair-like structures (cilia) that line the inside of your nose. These cilia sweep mucus and debris toward the throat, acting as a self-cleaning system for your airways.
In lab studies, benzalkonium chloride at a concentration of 0.1 mg/mL caused complete and irreversible stoppage of cilia movement. Even at half that concentration (0.05 mg/mL), it slowed cilia significantly. In living tissue, short-term exposure produced nasal pain and changes in mucus secretion. Repeated exposure raises concern about longer-term damage to the nasal lining, including a type of tissue change called squamous cell metaplasia, where the normal lining is replaced by a tougher, less functional layer. This isn’t a concern with occasional accidental exposure, but it matters if someone makes a habit of putting eye drops in their nose.
Prescription Eye Drops Carry Greater Risks
Over-the-counter redness relievers aren’t the only concern. Prescription eye drops for conditions like glaucoma contain potent medications designed to lower eye pressure. One common example, brimonidine, is absorbed through nasal mucosa and crosses into the brain, where it can cause sedation, significant drops in blood pressure, slowed heart rate, and central nervous system depression. These effects occur even through normal eye-to-nose drainage, which is why eye doctors sometimes recommend pressing on the inner corner of the eye after using glaucoma drops to block the drainage path. Putting such drops directly into the nose would amplify these risks considerably.
Children Are Especially Vulnerable
The risks jump dramatically for young children. The FDA has issued a specific safety warning about accidental ingestion or mucosal exposure to over-the-counter eye drops and nasal sprays containing imidazoline compounds in children five and younger. As little as 1 to 2 milliliters (less than half a teaspoon) can cause serious adverse events. For context, a standard eye drop bottle dispenses about 0.05 mL per drop, so roughly 20 to 40 drops’ worth could reach dangerous territory in a small child.
Reported symptoms in children include coma, severely slowed breathing, dangerously low heart rate, hypothermia, extreme drowsiness, and stupor. The FDA reviewed 53 cases that required hospitalization. Medical literature has documented that 2 to 5 mL of tetrahydrozoline 0.05% solution (the standard Visine concentration) is capable of producing coma in a child. Even smaller volumes, 1.5 to 3 mL, produced severe central nervous system and respiratory depression in an infant and a toddler.
If a child gets eye drops in their nose or mouth, contact Poison Control (1-800-222-1222 in the United States) and seek emergency care immediately. Do not wait for symptoms to appear.
Why It’s Not Worth the Risk
The practical appeal is understandable: you’re congested, there’s a bottle of Visine in the medicine cabinet, and the active ingredient is related to what’s in nasal sprays. But the formulation matters. Eye drops contain preservatives and inactive ingredients chosen for the eye’s surface, not the nasal lining. The concentration may be lower than a nasal spray, but the absorption is less predictable when you’re applying it to tissue it wasn’t designed for. And with actual nasal decongestant sprays and saline rinses readily available, there’s no practical reason to substitute eye drops for a product that’s been formulated and tested for nasal use.